These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early systemic sclerosis-opportunities for treatment. Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876 [TBL] [Abstract][Full Text] [Related]
5. Assessing microvascular changes in systemic sclerosis diagnosis and management. Cutolo M; Sulli A; Smith V Nat Rev Rheumatol; 2010 Oct; 6(10):578-87. PubMed ID: 20703220 [TBL] [Abstract][Full Text] [Related]
6. Vascular disease in systemic sclerosis. Poredos P Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075 [No Abstract] [Full Text] [Related]
7. A 77-year-old woman with dyspnea and raynaud phenomenon. Wang J; Sadoughi A; Dedopoulos S; Talwar A Chest; 2011 Apr; 139(4):958-961. PubMed ID: 21467065 [No Abstract] [Full Text] [Related]
8. Treatment Algorithms for Systemic Sclerosis According to Experts. Fernández-Codina A; Walker KM; Pope JE; Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586 [TBL] [Abstract][Full Text] [Related]
9. From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach. Bellando-Randone S; Matucci-Cerinic M Curr Rheumatol Rev; 2013; 9(4):245-8. PubMed ID: 26932288 [TBL] [Abstract][Full Text] [Related]
11. Management of cutaneous vascular complications in systemic scleroderma: experience from the German network. Herrgott I; Riemekasten G; Hunzelmann N; Sunderkötter C Rheumatol Int; 2008 Aug; 28(10):1023-9. PubMed ID: 18320192 [TBL] [Abstract][Full Text] [Related]
12. Limited cutaneous systemic sclerosis: report of one case. Lin MC; Fu LS; Huang KY; Tsen CF; Liou JM; Chi CS Acta Paediatr Taiwan; 2001; 42(4):248-51. PubMed ID: 11550416 [TBL] [Abstract][Full Text] [Related]
13. Drug treatment of scleroderma. Leighton C Drugs; 2001; 61(3):419-27. PubMed ID: 11293650 [TBL] [Abstract][Full Text] [Related]
14. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M; Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients. Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897 [TBL] [Abstract][Full Text] [Related]
16. [Coexistence of scleroderma-like syndrome and idiopathic myelofibrosis in a 54-year-old female patient: case report]. Domysławska I; Ciołkiewicz M; Kowal-Bielecka O; Lewszuk A; Klimiuk PA; Sierakowski S Pol Arch Med Wewn; 2007 Aug; 117(8):370-3. PubMed ID: 18018385 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of scleroderma peripheral vascular disease. Herrick A Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535 [TBL] [Abstract][Full Text] [Related]
18. [A case of systemic sclerosis in childhood complicated by severe digital ulcers]. Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137 [TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis. Nishibu A; Sakai E; Oyama N; Yamamoto T Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581 [TBL] [Abstract][Full Text] [Related]